[
 {
  "document": {
   "authors": "Priya S",
   "contact_info": "priya@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "32221306.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "HGNC",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MGI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "GO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "TAX",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "COVID",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "PUBCHEM",
     "type": "PATTERN",
     "value": "^\\d+$",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Custom_CellLine",
     "type": "LIST",
     "value": null,
     "value_list": [
      "17cl1",
      "HEK293/hACE"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Virus_type",
     "type": "LIST",
     "value": null,
     "value_list": [
      "pseudovirion"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "concentration",
     "type": "LIST",
     "value": null,
     "value_list": [
      "100 nM",
      "20 nM"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Treatment",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Trypsin"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Research"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Published"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Results"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.",
       "ref": "32221306",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Research"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Published"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Results"
       ]
      }
     },
     {
      "evidence": "Consistent with previous reports, 20mM NH4Cl and 100 nM bafilomycin A \\\ndecreased entry of SARS-CoV S and VSV-G pseudovirions by over 99%, \\\ncompared to no treatment control."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     },
     {
      "set": {
       "Virus_type": [
        "pseudovirion"
       ]
      }
     },
     {
      "set": {
       "concentration": [
        "20 nM"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "ammonium chloride"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "G protein, vesicular stomatitis virus"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "ammonium chloride"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "concentration"
      ]
     },
     {
      "set": {
       "concentration": [
        "100 nM"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "bafilomycin A1"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "G protein, vesicular stomatitis virus"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "bafilomycin A1"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "concentration"
      ]
     },
     {
      "unset": [
       "Virus_type"
      ]
     },
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "Inhibition of PIKfyve by apilimod significantly reduced entry of SARS- \\\nCoV S pseudovirions on 293/hACE2 cells in a dose dependent manner \\\n(Fig. 3b), whereas it had no effect on entry of VSV-G pseudovirions, \\\nwhich occurs in early endosomes."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "10173277"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "PIKFYVE"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "set": {
       "Virus_type": [
        "pseudovirion"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "10173277"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "10173277"
        }
       ]
      ]
     },
     {
      "relation": "causes_no_change"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "G protein, vesicular stomatitis virus"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Virus_type"
      ]
     },
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "Moreover, infection of live MHV on 17Cl.1 cells was also strongly \\\ninhibited by apilimod treatment (Fig. 3c)."
     },
     {
      "set": {
       "Custom_CellLine": [
        "17cl1"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "10173277"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Murine hepatitis virus"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "As expected, apilimod treatment inhibited entry of SARS-CoV-2 S \\\npseudovirions in a dose dependent manner (Fig. 3d)"
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "10173277"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "While blocking TPC2 activity by tetrandrine, an inhibitor for TPC237, \\\ndecreased entry of SARS-CoV-2 S pseudovirions (Fig. 3f), treatment of \\\ncells with 130, a TRPML1 inhibitor, had no effect (Supplementary Fig. \\\n1), indicating that TPC2, not TRPML1, is important for SARS-CoV-2 \\\nentry."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "(+)-Tetrandrine"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "MGI",
           "name": "Tpcn2"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "set": {
       "Virus_type": [
        "pseudovirion"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "(+)-Tetrandrine"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Virus_type"
      ]
     },
     {
      "evidence": "E64D treatment of 293/hACE2 cells reduced entry of SARS-CoV-2 S \\\npseudovirions by 92.5%, indicating that at least one of cathepsins or \\\ncalpain might be required for SARS-CoV-2 entry (Fig. 4a)."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "aloxistatin"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "While cathepsin B inhibitor treatment did not show any marked effect \\\non virus entry, cathepsin L inhibition treatment decreased entry of \\\nSARS-CoV-2 S pseudovirions into 293/hACE2 by over 76% (Fig. 4a), \\\nsuggesting that cathepsin L should be essential for priming of SARS- \\\nCoV-2 S protein in lysosome for entry into 293/hACE2 cells."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "16725315"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "CTSL"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "GO",
            "name": "lysosome"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "Consistent to our previous report23, addition of trypsin triggered \\\nsyncytium formation on 293/hACE2 cells by SARS-CoV S protein after 4 h \\\nincubation (Fig. 4b, c)."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     },
     {
      "set": {
       "Treatment": [
        "Trypsin"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Giant Cells"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Treatment"
      ]
     },
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "Of note, SARS-CoV-2, but not SARS-CoV, S proteins induced syncytia \\\nformation on 293/hACE2 cells even in the absence of trypsin (Fig. 4c), \\\nsuggesting that SARS-CoV-2 S proteins could be triggered upon the \\\nreceptor binding without exogenous protease priming or activation."
     },
     {
      "set": {
       "Custom_CellLine": [
        "HEK293/hACE"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Giant Cells"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "unset": [
       "Citation"
      ]
     }
    ]
   }
  ]
 }
]